Hepatocellular Cancer clinical trials at UCSF

• A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

  open to eligible people ages 18 years and up

  TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

  San Francisco, California and other locations

Last updated: December 7, 2021